Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.220ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.220ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.220ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.220NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.142ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.142ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.142ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.142NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.523ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.523ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.523ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.523NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.36.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.418ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.418ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.418NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.389ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.389ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.389ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.389NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.363ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.363ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.363ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.363NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.405ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.405ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.405ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.405NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.282ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.282ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.282ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.282NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.228ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.228ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.228ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.228NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.174ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.174ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used